U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Medical Devices
  3. Medical Devices News and Events
  4. Webinar – FDA’s Total Product Life Cycle Approach to In Vitro Diagnostic Products (IVDs) - 10/24/2024
  1. Medical Devices News and Events

Virtual | Virtual

Event Title
Webinar – FDA’s Total Product Life Cycle Approach to In Vitro Diagnostic Products (IVDs)
October 24, 2024

Date:
October 24, 2024
Time:
1:00 p.m. - 2:00 p.m. ET

Summary

On October 24, 2024, the U.S. Food and Drug Administration (FDA) held a webinar for laboratory manufacturers and other interested parties to discuss the FDA’s Total Product Life Cycle (TPLC) approach to the oversight of in vitro diagnostic products (IVDs). 

The FDA’s TPLC approach allows the FDA to review and monitor medical devices throughout their life cycle by taking into account all available information on safety and effectiveness. 

Webinar Materials

The presentation, printable slides, and transcript are available on this webpage and at CDRH Learn under "In Vitro Diagnostics."

If you have questions about this webinar, please contact CDRH's Division of Industry and Consumer Education (DICE) at dice@fda.hhs.gov, 1-800-638-2041, or 301-796-7100.

Back to Top